Are You a Good Candidate for Weight Loss Injections
Endocrine Development, In, pp 4973 Funding Financial support: Supported by the Medical University of Lodz (502-03/1-156-04/502-14-339 to HZ and 503/1-156-04/503-11-001 to JF)
C-JL: Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Visualization, Writing review & editing
Seven additional Phase 3 trials are expected to complete in 2026, potentially positioning retatrutide as the next major obesity therapy
Most interaction events documented in preclinical models occurred when both agents were administered within the same 2-hour window
Additionally, WA, the plant extracts main ingredient, exhibits potential as a major anti-cancer therapeutic [100]